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Background: Ocular TB is defined as an infection of Mycobac-
terium tuberculosis involving any part of the eye. Estimates of 1.4% of
patients with pulmonary tuberculosis have ocular involvement and
though rare, this presentation can have devastating consequences
if not recognised.
We present a case series of ocular TB diagnosed at London North
West Healthcare trust which serves a multicultural community
with the highest rates of TB infection in the UK.
Methods and materials: Retrospective analysis of laboratory
and medical records, radiology and microbiology results of patients
with ocular TB identified from the London TB register from
September 2012 to July 2019 from London North West Hospitals
University NHS Trust.
Results: 28 patients with ocular TB were identified: 23 uveitis
(10 anterior uveitis, 6 posterior uveitis, 7 panuveitis), 1 maculopa-
thy, 1 optic neuritis, 1 epislceritis, 1 orbital fibrovascular TB lesion
and 1 retinal periphlebitis. All were presumptive diagnoses with
only one having ocular microbiological samples obtained; which
were negative. 54% of cases were female, average age at diagno-
sis 48 years (range 22 to 72). 89.3% were migrants; 29% African
and 61% South Asian, particularly Indian (39%). Average time from
symptoms presenting to treatment commencing was 186 days.
Only 2 patients had evidence of TB at other sites; both extra-
pulmonary (mediastinal and extra thoracic lymph nodes). 1 patient
was HIV positive.
Nine patients (32.6%) received steroids (3 eye drops and 6 sys-
temic therapies). Nearly all patients had either a reactive Mantoux
test (10) or Interferon Gamma Release Assay (17). Treatment dura-
tion was usually the standard 6 months (57%) followed by 9 months
(19%), 12 months (19%) and 13 months (5%) with 2 patients lost to
follow up. 19 patients (67.9%) were treated with ethambutol spar-
ing regimens usually replacing with moxifloxacin. 1 patient had
blindness as a long term sequaela of ocular TB.
Conclusion: Our case series demonstrates that ocular tubercu-
losis frequently occurs in the absence of pulmonary tuberculosis
and should be considered in all cases of uveitis in patients from
endemic regions.
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